About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Vascular Improvement With Olmesartan Medoxomil Study

Vascular Improvement With Olmesartan Medoxomil Study

NCT00772499·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Daiichi Sankyo

Age

18–75

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Male or female
18-75 years of age
Mean seated diastolic BP 90-109 or mean seated systolic BP of 140-179

You may not be if

Secondary hypertension
Renal disease
Diabetes mellitus
Serum creatinine \>3.0 mg/dL
Hemoglobin \<10 mg/dL (males) or \<9mg/dL (females)
WBC count \<2000 cells/mL
Platelet count \<100,000 cells/mL
Either ALT \& AST \>2.5 x upper limit of normal
BMI \>35 kg/m2
TIA or cerebrovascular attack within 3 months of study entry

The record

StatusCompleted

PhasePhase 4

Taking part100

StartedNov 2002

UpdatedOct 15, 2008

Conditions

Where1

Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina, United States